Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Best Antidepressant Options for Depression with Weight Concerns

Antidepressant Options Based on Weight Effects

  • Bupropion is the only antidepressant consistently associated with weight loss through appetite suppression and reduced food cravings 1, 2, 3
  • Bupropion functions as a norepinephrine and dopamine reuptake inhibitor and is FDA-approved for depression and smoking cessation 3
  • Bupropion was later approved by the FDA in 2014 for chronic weight management in combination with naltrexone (Contrave) 3
  • Fluoxetine and sertraline are associated with short-term weight loss and long-term weight neutrality 1, 3
  • Paroxetine has the highest risk for weight gain among SSRIs 1, 3
  • Amitriptyline has the highest risk for weight gain among tricyclic antidepressants 1, 3
  • Lithium, mirtazapine, and monoamine oxidase inhibitors are also closely associated with significant weight gain 1, 3

Important Clinical Considerations

  • All second-generation antidepressants are equally effective for treatment-naïve patients with depression 4
  • The American College of Physicians recommends selecting antidepressants based on adverse effect profiles, cost, and patient preferences 5
  • Antidepressants are most effective in patients with severe depression 4
  • Bupropion is activating and may exacerbate anxiety or be inappropriate for patients with bipolar disorder 3
  • Bupropion is not suitable for all types of depression, so the specific depression subtype must be considered 1, 3
  • Regular monitoring is essential, beginning 1-2 weeks after initiation of therapy to assess therapeutic response and adverse effects 5

Monitoring and Follow-up

  • Assess patient status, therapeutic response, and adverse effects regularly, beginning within 1-2 weeks of starting therapy 5
  • Consider modifying treatment if there is inadequate response within 6-8 weeks of initiation 5
  • Treatment for a first episode of major depression should last at least four months, with longer treatment beneficial for recurrent depression 4

Specific Recommendations for Different Patient Scenarios

  • For patients with comorbid anxiety, consider sertraline or fluoxetine rather than bupropion 3, 4
  • For elderly patients, preferred agents include citalopram, escitalopram, sertraline, and bupropion due to better tolerability 4
  • For patients with bipolar disorder, avoid bupropion and antidepressant monotherapy; mood stabilizers should be the primary treatment 6

Common Pitfalls to Avoid

  • Failing to monitor weight changes regularly during treatment 3
  • The choice of antidepressant must still be guided by the specific type of depression and individual patient circumstances 3